# The Use Of FFR Guided PCI Versus Complete Revascularization and Treatment Of Infarct Related Artery Only In Patients With STEMI

Study · id `cardio:ct-nct02637440` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02637440](<https://clinicaltrials.gov/study/NCT02637440>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02637440

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 560 participants.

## Technical summary

Registry record NCT02637440. Randomized; no masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2019-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 560 participants (planned count; ClinicalTrials.gov record NCT02637440, source copy `cardio:ctgov-nct02637440-2015-12-23`, retrieved 2026-10-26)
- Start date: 2015-12 (registry gives no type) (ClinicalTrials.gov record NCT02637440, source copy `cardio:ctgov-nct02637440-2015-12-23`, retrieved 2026-10-26)
- Primary completion: 2019-11 (anticipated) (ClinicalTrials.gov record NCT02637440, source copy `cardio:ctgov-nct02637440-2015-12-23`, retrieved 2026-10-26)
- Completion: 2019-11 (anticipated) (ClinicalTrials.gov record NCT02637440, source copy `cardio:ctgov-nct02637440-2015-12-23`, retrieved 2026-10-26)
- Countries: Ireland (ClinicalTrials.gov record NCT02637440, source copy `cardio:ctgov-nct02637440-2015-12-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02637440-2015-12-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Use Of FFR Guided PCI Versus Complete Revascularization and Treatment Of Infarct Related Artery Only In Patients With STEMI
- Acronym: FAIO
- Condition: Multivessel Coronary Artery Disease
- Condition: STEMI
- Condition: FFR Guided PCI
- Intervention (Procedure): FFR guided PCI
- Intervention (Procedure): Angio guided PCI
- Lead sponsor: University of Limerick
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)

## Provenance

Content hash: e96401a4e4dfa7472caad6f014a8fdd0ec9eaa26aec21ae39a00175fced18f6f
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
